Orphan Drugs Market Top Companied are AbbVie Inc., Aegerion Pharmaceuticals, Bristol-Myers Squibb Company, Celgene Corporation

“Orphan Drugs Market by Disease Type and Indication: Global Opportunity Analysis and Industry Forecast, 2014-2022,” the global orphan drugs market was valued at $106 billion in 2015, and is projected to reach $169 billion by 2022, growing at a CAGR of 6.8% from 2016 to 2022. The oncology disease segment held nearly one-thirds of the market share in 2015. Orphan drugs are specialized pharmaceutical agents that are administered for treatment of rare (orphan) diseases. These diseases have a very low prevalence rate, hence, pharmaceutical companies do not readily invest in these drugs as the returns on investment…

Read More